Last update: July 6, 2018

ميثيلفينيدات

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

A central nervous system stimulant and indirect sympathomimetic with actions and indications similar to dexamfetamine.
Indicated in attention-deficit hyperactivity disorder (ADHD) and in narcolepsy.
Oral administration 1 to 3 times a day.

It is excreted in breastmilk in clinically insignificant amounts or not at all (Collin 2018, Bolea 2014, Spigset 2007, Hackett 2006) and no short or long term problems have been observed in infants whose mothers were taking it (Collin 2018, Rowe 2013, Bolea 2014, Spigset 2007, Hackett 2006).
The plasma levels of these infants were undetectable or very low (Bolea 2014, Hackett 2006).

Several medical associations and experts consider the use of this medication to be safe during breastfeeding (Calvo 2018, Collin 2018, Ornoy 2018, Marchese 2015, Rowe 2013).

Some authors suggest clinically monitoring weight gain and possible irritability in the infant (Marchese 2015, Rowe 2013).

Methylphenidate does not influence prolactin levels on a regular basis (Janowsky 1978).

Alternatives

We do not have alternatives for ميثيلفينيدات since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

ميثيلفينيدات is Methylphenidate in Arabic.

Is written in other languages:

ميثيلفينيدات is also known as

Group

ميثيلفينيدات belongs to this group or family:

Tradenames

Main tradenames from several countries containing ميثيلفينيدات in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 22 ± 8 %
Molecular weight 233 daltons
Protein Binding 10 - 33 %
VD 1,8 - 2,65 l/Kg
pKa 8,77 -
Tmax 2 - 3 hours
T1/2 1 - 4 hours
M/P ratio 2,8 -
Theoretical Dose 0,003 mg/Kg/d
Relative Dose 0,3 %

References

  1. Collin-Lévesque L, El-Ghaddaf Y, Genest M, Jutras M, Leclair G, Weisskopf E, Panchaud A, Ferreira E. Infant Exposure to Methylphenidate and Duloxetine During Lactation. Breastfeed Med. 2018 Abstract
  2. Calvo-Ferrandiz E, Peraita-Adrados R. Narcolepsy with cataplexy and pregnancy: a case-control study. J Sleep Res. 2018 Apr;27(2):268-272. Abstract Full text (link to original source)
  3. Ornoy A. Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation. Pharm Res. 2018 Abstract
  4. Marchese M, Koren G, Bozzo P. Is it safe to breastfeed while taking methylphenidate? Can Fam Physician. 2015 Abstract Full text (link to original source) Full text (in our servers)
  5. Bolea-Alamanac BM, Green A, Verma G, Maxwell P, Davies SJ. Methylphenidate use in pregnancy and lactation: a systematic review of evidence. Br J Clin Pharmacol. 2014 Abstract Full text (link to original source) Full text (in our servers)
  6. Rowe H, Baker T, Hale TW. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am. 2013 Feb;60(1):275-94. Abstract
  7. Spigset O, Brede WR, Zahlsen K. Excretion of methylphenidate in breast milk. Am J Psychiatry. 2007 Abstract Full text (link to original source) Full text (in our servers)
  8. Hackett LP, Kristensen JH, Hale TW, Paterson R, Ilett KF. Methylphenidate and breast-feeding. Ann Pharmacother. 2006 Abstract Full text (link to original source) Full text (in our servers)
  9. Janowsky DS, Leichner P, Parker D, Judd L, Huey L, Clopton P. Methylphenidate and serum prolactin in man. Psychopharmacology (Berl). 1978 Abstract

Total visits

359

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM